Quantification of doxycycline hyclate in tablets by HPLC-UV method
Ana Carolina Kogawa1, Hérida Regina Nunes Salgado
1Department of Drugs and Medicines, Faculty of Pharmaceutical Sciences of Araraquara, Universidade Estadual Paulista "Júlio de Mesquita Filho"-UNESP, Araraquara, São Paulo, Brazil.
A new high-performance liquid chromatography method accurately quantifies doxycycline hyclate in bulk drugs and tablets. This validated method ensures reliable quality control for pharmaceutical products.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Analysis
Background:
- Doxycycline hyclate is a widely used antibiotic.
- Accurate quantification is crucial for pharmaceutical quality control.
Purpose of the Study:
- To develop and validate a rapid and sensitive analytical method for doxycycline hyclate determination.
- To assess the method's suitability under various stress conditions.
Main Methods:
- Gradient reversed-phase high-performance liquid chromatography (RP-HPLC) was employed.
- A CN Luna column with a specific mobile phase (water + 0.1% TFA-acetonitrile + 0.1% TFA) was used.
- Ultraviolet detection at 360 nm and ambient temperature (25°C) were utilized.
Main Results:
- The method demonstrated linearity over a 50-100 µg/mL range (r = 0.9999).
- Limits of detection (LOD) and quantification (LOQ) were 2.83 µg/mL and 8.59 µg/mL, respectively.
- The method proved suitable despite degradation product interference under stress conditions, showing excellent recoveries in pharmaceutical samples.
Conclusions:
- The developed RP-HPLC method is accurate, sensitive, precise, and rapid for doxycycline hyclate analysis.
- This method is suitable for routine quality control of doxycycline hyclate in bulk drug and tablet formulations.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Related Concept Videos
Drug Dissolution: Requirements and Profile Comparison
Clinically Relevant Drug Product Specifications: Methods of Establishment
Dosage Interval and Administration Route: Determination Methods
